RALEIGH, N.C., June 11 /PRNewswire/ --PRA International, a leading Clinical Research Organization (CRO), will host five interactive round-table sessions on drug development and lifecycle management at the Drug Information Association's (DIA) annual meeting in Washington, D.C. 13-17 June 2010.
Drug development and lifecycle management have never been more challenging and the ground is constantly shifting in this area. To discuss solutions to the field's toughest issues and latest developments, conference attendees can join PRA at booth 901 for expert round-table sessions. These highly interactive forums will review:
- The challenges and benefits of reporting serious adverse events using electronic data capture systems.
- Attributes of high-performing teams between biopharma companies and their CRO partners.
- Risk evaluation and mitigation strategies and post-marketing commitments.
- Using clinical informatics to achieve successful patient recruitment and retention.
- Information lifecycle management — improving access to critical information.
PRA will also exhibit at booth 901, where attendees can learn more about our broad range of services. Along with representatives from all of PRA's services, leaders of the following PRA business units will be in attendance: Business Development, Clinical Informatics, Clinical Operations (Americas), Corporate Services, IT, Late Phase Services, Patient Recruitment and Retention, Safety & Risk Management Services, and the PRA Infectious Disease Research Center.
To reserve your seat for a DIA round-table session, please send an email to firstname.lastname@example.org or see a PRA representative at DIA, booth 901.
About PRA International
PRA International conducts clinical trials in more than 75 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. In the last five years, PRA has supported over 2,700 clinical trials through its 37 global offices.
PRA's therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on-time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.
SOURCE PRA International